DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children
DBV Announced Results of its 2016 Annual Meeting of Shareholders
Société Générale - Conférence Healthcare & BiotechnologyParis
2016 AAAAI Annual Meeting
The 2016 AAAAI Annual Meeting (American Academy of Allergy, Asthma and Immunology) took place in Los Angeles from March 4th to 7th.